JCV Antibody Program (STRATIFY-1)
| Status: | Archived |
|---|---|
| Conditions: | Neurology, Multiple Sclerosis |
| Therapuetic Areas: | Neurology, Other |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | March 2010 |
| End Date: | August 2012 |
JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1
Study conducted to define the prevalence of Serum JC Antibody in relapsing MS patients
receiving Tysabri or being considered for such treatment.
Analytically validate the JCV antibody assay in a plasma matrix.
This study requires blood and urine collection @ enrollment and every 6 months thereafter
for up two years.
We found this trial at
10
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials